SlideShare uma empresa Scribd logo
1 de 15
Baixar para ler offline
Cannabis, Cognitive
Functions and Driving:
The Visual System
CAROLINA CANNABINOID
CONFERENCE 2015
Acknowledgements
Declarations
 Previous Alzheimer’s disease funding, Forest
Laboratories and NIH/NIA
 No funding for the review work related to cannabis
 Currently associated with VisionCare/IMMAD and
the development of hand held technology using
temporal vision targets of variable contrast to detect
impairment to drive secondary to cannabis
consumption.
 This is an abbreviated version of the presentation.
Neuroprocessing
Dysfunction in Visual Pathways
 Occurs in age related neurodegenerative disease
 Examples: Parkinson’s disease and Alzheimer’s disease
 Occurs with cannabis use
 Dysfunctions in vision processing with cannabis use and
the neurodegenerative disease, Alzheimer’s, have
numerous similarities
AD, PD and Cannabis
Produce Dysfunction In
Magnocellular Pathway
 Involved in integration processes
in the major relay brain region
the Lateral Geniculate Nucleus
 Spatial Depth Perception
 Motion Processing
 Contrast Sensitivity
 Speed Detection
Lateral Geniculate Nucleus
Photo: Penn State Neuroanatomy BB 1-1297a
Cannabinoid Receptors
Brain Nucleus Lateral Geniculate
The primate lateral geniculate nucleus has
cannabinoid receptors throughout.
The functional layers are stained to show
CB1 receptors
Blue Magnocellular: Achromatic functions
Red Parvocelluar: Red Green Functions
Green Koniocellular: Blue Functions
Javadi P: Neuroscience. 2015 Mar 12;288:135-44.
Cannabinoids
Visual Function Paper Concluded
 …the first insight into the neuroanatomy of
CB1R…expression in the primate LGN…
 the presence… in the magnocellular pathway suggests…
 That actions of the visual pathway involved in motion
perception, object localization and action-oriented
behaviors that depend on the perception of space…
 In other words: CB1 Receptors impact visual functions
critical for safe driving
 Cannabis consumption inhibits many of the functions
Excitation
Inhibition CB1
 The LGN has two populations of CB1 cells
 28% are excitatory
 72% are inhibitory
Dasilva MA: Psychopharmacology (Berl). 2012 Feb;219(3):835-45.
http://spie.org/x112010.xml
Lateral Geniculate
Nucleus Response To Cannabis
 CB1 LGN functioning in primate model showed that THC inhibited
cells that would normally fire when exposed to light
 Cells that would be normally be inhibited by light were either
unresponsive with no inhibition activity or had an abnormal
heightened excitation
 This has significant implications for the interaction of central
macular retinal functions and peripheral retinal functions as well as
scotopic (night or dark) and photopic (day or light) functions
 And functions that are integrative such as motion detection and all
other functions in the magnocellular pathway
Bieger D: Neuropharmacology. 1973 Mar;12(3):269-73.
Cannabinoid Receptors
Demonstrated Human Retina
Cannabinoid CB1
receptors are in the
retina
Yellow arrows show
cone pedicle and rod
spherules stained
demonstrating CB1
A Straiker A: Proc Natl Acad
Sci. 1999 Dec
7;96(25):14565-70
Cannabis Consumption
Dysfunction In Glare Response
 Research has shown that in humans, the time to
recover normal retinal function after a bright light
exposure is significantly longer with the
consumption of cannabis.
Adams A: Psychopharmacology, 56, 81-86, 1978
Color Dysfunction With
Cannabis Consumption
 The structural findings related to the cones in the
retina and koniocellular layers of the LGN may
account for the functional findings of color
impairment with cannabis consumption. Several
researchers have identified color deficits along
the blue axis.
Dawson WW: Invest Ophthalmol Vis Sci. 1977 Aug;16(8):689-99.
Adams A: J Optom Physiol Opt. 1975 Nov;52(11):729-35.
Adams A: Perception and Psychophysics, 1976:20(2):119-124.
Driving Issues
 Cannabis impairs driving
 The prominent error with cannabis is lane deviation
Hartman RL: Drug Alcohol Depend. 2015 Sep 1;154:25-37.
Visual dysfunctions contributing to this: Poor spatial processing,
reduced depth perception, dysfunctional processing of motion
and speed………..
 Alzheimer’s disease impairs driving
 A prominent error with Alzheimer’s disease is lane deviation
Griffith HR: J Geriatr Psychiatry Neurol. 2013 Dec;26(4):259-66.
One Year Legal
Recreational Use in Colorado
 The rate of drivers involved in fatal crashes that
test positive for cannabis has doubled
 The driving errors are lane deviations
 Head on collisions occur with lane deviations
 Fatal crash with lane deviation (Vermont),
driver that deviated out of lane tested positive
for cannabis and survived, other driver killed
Maintaining Lane Position
Cannabis Differs From Alcohol
 Two different doses (100 and 200mg) of cannabis were used
to determine standard deviation of lateral position (SDLP),
time driven out of lane (TOL), reaction time (RT) and
standard deviation of headway (SDH).
 Both THC doses alone, and alcohol alone, significantly
impaired the subjects performances in driving tests.
 Performance deficits were smaller after acohol and
moderate after both THC doses.
 Combining THC with alcohol dramatically impaired driving
performance.
. Ramaekers J: Hum Psychopharmacol. 2000 Oct;15(7):551-558.

Mais conteúdo relacionado

Destaque

10 conditions cannabis can help
10 conditions cannabis can help10 conditions cannabis can help
10 conditions cannabis can help
Molly Blakemore
 
Cannabinoids Jonny A.
Cannabinoids Jonny A.Cannabinoids Jonny A.
Cannabinoids Jonny A.
vacagodx
 
Gonadal hormones and inhibitors
Gonadal hormones and inhibitorsGonadal hormones and inhibitors
Gonadal hormones and inhibitors
MD Specialclass
 
Menopause management seminar
Menopause management seminarMenopause management seminar
Menopause management seminar
obsgynhsnz
 

Destaque (19)

Hemp
HempHemp
Hemp
 
K2 and Beyond: A Synthetic Cannabinoid Primer
K2 and Beyond: A Synthetic Cannabinoid PrimerK2 and Beyond: A Synthetic Cannabinoid Primer
K2 and Beyond: A Synthetic Cannabinoid Primer
 
Physiology and pharmacology of nausea and emesis 2015 jap
Physiology and pharmacology of nausea and emesis 2015 japPhysiology and pharmacology of nausea and emesis 2015 jap
Physiology and pharmacology of nausea and emesis 2015 jap
 
10 conditions cannabis can help
10 conditions cannabis can help10 conditions cannabis can help
10 conditions cannabis can help
 
Cannabinoids Jonny A.
Cannabinoids Jonny A.Cannabinoids Jonny A.
Cannabinoids Jonny A.
 
Synthetic cannabinoids
Synthetic cannabinoidsSynthetic cannabinoids
Synthetic cannabinoids
 
Endocannabinoid receptors possible treatment target for type 2 dm
Endocannabinoid receptors   possible treatment target for type 2 dmEndocannabinoid receptors   possible treatment target for type 2 dm
Endocannabinoid receptors possible treatment target for type 2 dm
 
Cannabinoides slide share
Cannabinoides slide shareCannabinoides slide share
Cannabinoides slide share
 
Medical Cannabis in Cancer Treatment
Medical Cannabis in Cancer TreatmentMedical Cannabis in Cancer Treatment
Medical Cannabis in Cancer Treatment
 
Menopause and obesity
Menopause and obesityMenopause and obesity
Menopause and obesity
 
THC
THCTHC
THC
 
K2 and the Synthetic Cannabinoids: Pharmacology, Effects and Chemical Analysis
K2 and the Synthetic Cannabinoids: Pharmacology, Effects and Chemical AnalysisK2 and the Synthetic Cannabinoids: Pharmacology, Effects and Chemical Analysis
K2 and the Synthetic Cannabinoids: Pharmacology, Effects and Chemical Analysis
 
PPT ON 50 AYURVEDIC DRUGS BY DR SIBA PRASAD ROUT,IPGT
PPT ON 50 AYURVEDIC DRUGS BY DR SIBA PRASAD ROUT,IPGTPPT ON 50 AYURVEDIC DRUGS BY DR SIBA PRASAD ROUT,IPGT
PPT ON 50 AYURVEDIC DRUGS BY DR SIBA PRASAD ROUT,IPGT
 
Cannabinoids
CannabinoidsCannabinoids
Cannabinoids
 
pharmacology of cannabinoid
pharmacology of cannabinoidpharmacology of cannabinoid
pharmacology of cannabinoid
 
Jone's fracture by Dr.Mahbub
Jone's fracture by Dr.MahbubJone's fracture by Dr.Mahbub
Jone's fracture by Dr.Mahbub
 
Reverse pharmacognosy
Reverse pharmacognosyReverse pharmacognosy
Reverse pharmacognosy
 
Gonadal hormones and inhibitors
Gonadal hormones and inhibitorsGonadal hormones and inhibitors
Gonadal hormones and inhibitors
 
Menopause management seminar
Menopause management seminarMenopause management seminar
Menopause management seminar
 

Semelhante a Carolina Cannabinoid PDF

2010community Lecture
2010community Lecture2010community Lecture
2010community Lecture
Diana Kerwin
 
BIOMARKERS AND SCHIZOPHRENIA1233445677.ppt
BIOMARKERS AND SCHIZOPHRENIA1233445677.pptBIOMARKERS AND SCHIZOPHRENIA1233445677.ppt
BIOMARKERS AND SCHIZOPHRENIA1233445677.ppt
RobinBaghla
 
Positron emission tomographic scan
Positron emission tomographic scanPositron emission tomographic scan
Positron emission tomographic scan
Prashant Makhija
 
Chronic Neuroinflammation in Alzheimer’s Disease New Perspectives Animal Mode...
Chronic Neuroinflammation in Alzheimer’s Disease New Perspectives Animal Mode...Chronic Neuroinflammation in Alzheimer’s Disease New Perspectives Animal Mode...
Chronic Neuroinflammation in Alzheimer’s Disease New Perspectives Animal Mode...
Niloo Karunaweera
 
Pharmacological neuroprotection in blinding eye diseases
 Pharmacological neuroprotection in blinding eye diseases Pharmacological neuroprotection in blinding eye diseases
Pharmacological neuroprotection in blinding eye diseases
Alexander Decker
 

Semelhante a Carolina Cannabinoid PDF (20)

Dementia overview
Dementia overviewDementia overview
Dementia overview
 
2010community Lecture
2010community Lecture2010community Lecture
2010community Lecture
 
Reversible Dementia Induced by VEGFR-Tkis: A Case Report and Literature Review
Reversible Dementia Induced by VEGFR-Tkis: A Case Report and Literature ReviewReversible Dementia Induced by VEGFR-Tkis: A Case Report and Literature Review
Reversible Dementia Induced by VEGFR-Tkis: A Case Report and Literature Review
 
BIOMARKERS AND SCHIZOPHRENIA1233445677.ppt
BIOMARKERS AND SCHIZOPHRENIA1233445677.pptBIOMARKERS AND SCHIZOPHRENIA1233445677.ppt
BIOMARKERS AND SCHIZOPHRENIA1233445677.ppt
 
Statistical, Energy Values And Peak Analysis (SEP) Approach For Detection of ...
Statistical, Energy Values And Peak Analysis (SEP) Approach For Detection of ...Statistical, Energy Values And Peak Analysis (SEP) Approach For Detection of ...
Statistical, Energy Values And Peak Analysis (SEP) Approach For Detection of ...
 
Mobley
MobleyMobley
Mobley
 
Positron emission tomographic scan
Positron emission tomographic scanPositron emission tomographic scan
Positron emission tomographic scan
 
Circadian rhythms and related disorders
Circadian rhythms and related disordersCircadian rhythms and related disorders
Circadian rhythms and related disorders
 
Molecular Substrates of Drug Abuse in a Schizophrenic Population
Molecular Substrates of Drug Abuse in a Schizophrenic PopulationMolecular Substrates of Drug Abuse in a Schizophrenic Population
Molecular Substrates of Drug Abuse in a Schizophrenic Population
 
Dementia syndromes associated with the consumption of alcohol and alcoholic d...
Dementia syndromes associated with the consumption of alcohol and alcoholic d...Dementia syndromes associated with the consumption of alcohol and alcoholic d...
Dementia syndromes associated with the consumption of alcohol and alcoholic d...
 
multiple system atrophy-newer developments
multiple system atrophy-newer developmentsmultiple system atrophy-newer developments
multiple system atrophy-newer developments
 
Chronic Neuroinflammation in Alzheimer’s Disease New Perspectives Animal Mode...
Chronic Neuroinflammation in Alzheimer’s Disease New Perspectives Animal Mode...Chronic Neuroinflammation in Alzheimer’s Disease New Perspectives Animal Mode...
Chronic Neuroinflammation in Alzheimer’s Disease New Perspectives Animal Mode...
 
Newer treatment modalities of glaucoma
Newer treatment modalities of glaucomaNewer treatment modalities of glaucoma
Newer treatment modalities of glaucoma
 
A guideline for discontinuing antiepileptic drugs in seizure-free patients – ...
A guideline for discontinuing antiepileptic drugs in seizure-free patients – ...A guideline for discontinuing antiepileptic drugs in seizure-free patients – ...
A guideline for discontinuing antiepileptic drugs in seizure-free patients – ...
 
Dr Amit Chougule Recent advances in psychiatry
Dr Amit Chougule Recent advances in psychiatry Dr Amit Chougule Recent advances in psychiatry
Dr Amit Chougule Recent advances in psychiatry
 
Electrophysiological assessment of optic neuritis: is there still a role
Electrophysiological assessment of optic neuritis: is there still a roleElectrophysiological assessment of optic neuritis: is there still a role
Electrophysiological assessment of optic neuritis: is there still a role
 
Cannabinoids For The Treatment Of Movement Disorders by Juan Sanchez-Ramos, M...
Cannabinoids For The Treatment Of Movement Disorders by Juan Sanchez-Ramos, M...Cannabinoids For The Treatment Of Movement Disorders by Juan Sanchez-Ramos, M...
Cannabinoids For The Treatment Of Movement Disorders by Juan Sanchez-Ramos, M...
 
Delirium in icu
Delirium in icuDelirium in icu
Delirium in icu
 
i29.full
i29.fulli29.full
i29.full
 
Pharmacological neuroprotection in blinding eye diseases
 Pharmacological neuroprotection in blinding eye diseases Pharmacological neuroprotection in blinding eye diseases
Pharmacological neuroprotection in blinding eye diseases
 

Carolina Cannabinoid PDF

  • 1. Cannabis, Cognitive Functions and Driving: The Visual System CAROLINA CANNABINOID CONFERENCE 2015
  • 2. Acknowledgements Declarations  Previous Alzheimer’s disease funding, Forest Laboratories and NIH/NIA  No funding for the review work related to cannabis  Currently associated with VisionCare/IMMAD and the development of hand held technology using temporal vision targets of variable contrast to detect impairment to drive secondary to cannabis consumption.  This is an abbreviated version of the presentation.
  • 3. Neuroprocessing Dysfunction in Visual Pathways  Occurs in age related neurodegenerative disease  Examples: Parkinson’s disease and Alzheimer’s disease  Occurs with cannabis use  Dysfunctions in vision processing with cannabis use and the neurodegenerative disease, Alzheimer’s, have numerous similarities
  • 4. AD, PD and Cannabis Produce Dysfunction In Magnocellular Pathway  Involved in integration processes in the major relay brain region the Lateral Geniculate Nucleus  Spatial Depth Perception  Motion Processing  Contrast Sensitivity  Speed Detection
  • 5. Lateral Geniculate Nucleus Photo: Penn State Neuroanatomy BB 1-1297a
  • 6. Cannabinoid Receptors Brain Nucleus Lateral Geniculate The primate lateral geniculate nucleus has cannabinoid receptors throughout. The functional layers are stained to show CB1 receptors Blue Magnocellular: Achromatic functions Red Parvocelluar: Red Green Functions Green Koniocellular: Blue Functions Javadi P: Neuroscience. 2015 Mar 12;288:135-44.
  • 7. Cannabinoids Visual Function Paper Concluded  …the first insight into the neuroanatomy of CB1R…expression in the primate LGN…  the presence… in the magnocellular pathway suggests…  That actions of the visual pathway involved in motion perception, object localization and action-oriented behaviors that depend on the perception of space…  In other words: CB1 Receptors impact visual functions critical for safe driving  Cannabis consumption inhibits many of the functions
  • 8. Excitation Inhibition CB1  The LGN has two populations of CB1 cells  28% are excitatory  72% are inhibitory Dasilva MA: Psychopharmacology (Berl). 2012 Feb;219(3):835-45. http://spie.org/x112010.xml
  • 9. Lateral Geniculate Nucleus Response To Cannabis  CB1 LGN functioning in primate model showed that THC inhibited cells that would normally fire when exposed to light  Cells that would be normally be inhibited by light were either unresponsive with no inhibition activity or had an abnormal heightened excitation  This has significant implications for the interaction of central macular retinal functions and peripheral retinal functions as well as scotopic (night or dark) and photopic (day or light) functions  And functions that are integrative such as motion detection and all other functions in the magnocellular pathway Bieger D: Neuropharmacology. 1973 Mar;12(3):269-73.
  • 10. Cannabinoid Receptors Demonstrated Human Retina Cannabinoid CB1 receptors are in the retina Yellow arrows show cone pedicle and rod spherules stained demonstrating CB1 A Straiker A: Proc Natl Acad Sci. 1999 Dec 7;96(25):14565-70
  • 11. Cannabis Consumption Dysfunction In Glare Response  Research has shown that in humans, the time to recover normal retinal function after a bright light exposure is significantly longer with the consumption of cannabis. Adams A: Psychopharmacology, 56, 81-86, 1978
  • 12. Color Dysfunction With Cannabis Consumption  The structural findings related to the cones in the retina and koniocellular layers of the LGN may account for the functional findings of color impairment with cannabis consumption. Several researchers have identified color deficits along the blue axis. Dawson WW: Invest Ophthalmol Vis Sci. 1977 Aug;16(8):689-99. Adams A: J Optom Physiol Opt. 1975 Nov;52(11):729-35. Adams A: Perception and Psychophysics, 1976:20(2):119-124.
  • 13. Driving Issues  Cannabis impairs driving  The prominent error with cannabis is lane deviation Hartman RL: Drug Alcohol Depend. 2015 Sep 1;154:25-37. Visual dysfunctions contributing to this: Poor spatial processing, reduced depth perception, dysfunctional processing of motion and speed………..  Alzheimer’s disease impairs driving  A prominent error with Alzheimer’s disease is lane deviation Griffith HR: J Geriatr Psychiatry Neurol. 2013 Dec;26(4):259-66.
  • 14. One Year Legal Recreational Use in Colorado  The rate of drivers involved in fatal crashes that test positive for cannabis has doubled  The driving errors are lane deviations  Head on collisions occur with lane deviations  Fatal crash with lane deviation (Vermont), driver that deviated out of lane tested positive for cannabis and survived, other driver killed
  • 15. Maintaining Lane Position Cannabis Differs From Alcohol  Two different doses (100 and 200mg) of cannabis were used to determine standard deviation of lateral position (SDLP), time driven out of lane (TOL), reaction time (RT) and standard deviation of headway (SDH).  Both THC doses alone, and alcohol alone, significantly impaired the subjects performances in driving tests.  Performance deficits were smaller after acohol and moderate after both THC doses.  Combining THC with alcohol dramatically impaired driving performance. . Ramaekers J: Hum Psychopharmacol. 2000 Oct;15(7):551-558.